Skip to content

Perioperative Melatonin in Lumbar Laminectomy

Perioperative Analgesic and Anxiolytic Effect of Melatonin in Patients Undergoing Lumbar Laminectomy

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01126294
Enrollment
84
Registered
2010-05-19
Start date
2010-04-30
Completion date
2011-09-30
Last updated
2010-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain and Anxiety in Patients Undergoing Surgery for Lumbar Laminectomy.

Keywords

lumbar laminectomy, melatonin, perioperative, pain, anxiety, analgesia, VAS score

Brief summary

Patients undergoing lumbar laminectomy surgery will receive either 5 or 10 mg melatonin or placebo once the evening before surgery and again 90 minutes before surgery. Pain and anxiety will be assessed over the 24 hour period following surgery.

Interventions

DIETARY_SUPPLEMENT5 mg melatonin

Patients will receive 5 mg melatonin once the evening before surgery and then again at 90 minutes before surgery.

DIETARY_SUPPLEMENT10 mg melatonin

Patients will receive 10 mg melatonin once the evening before surgery and then again at 90 minutes before surgery.

DIETARY_SUPPLEMENTPlacebo

Patients will receive placebo once the evening before surgery and then again at 90 minutes before surgery.

Sponsors

University Health Network, Toronto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age 18 to 65 years old * ASA status 1-3 * having lumbar laminectomy 2 to 3 levels with or without fusion

Exclusion criteria

* receiving emergent procedure * surgery for neoplastic spine lesion * allergy to melatonin or its non-medicinal ingredients * allergy or contraindication * BMI over 35 or or less than 20 kg/m2 * pregnancy or breastfeeding * failure to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Pain24 hoursPain will be assessed over a 24 hour period following surgery using a visual analogue scale
Anxiety24 hoursAnxiety will be assessed over a 24 hour following surgery using visual analogue scale

Countries

Canada

Contacts

Primary ContactPhilip Peng, MD
philip.peng@uhn.on.ca416 603-5118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026